Orchard Therapeutics Plc ADR (ORTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -95,212 | -44,296 | -144,584 | -108,236 | -71,791 |
| Depreciation Amortization | 1,279 | 622 | 2,804 | 1,915 | 950 |
| Income taxes - deferred | N/A | 787 | 1,131 | 758 | N/A |
| Accounts receivable | -2,997 | -2,719 | -624 | -213 | 893 |
| Accounts payable and accrued liabilities | N/A | 3,815 | N/A | -9,473 | -14,341 |
| Other Working Capital | 14,202 | 12,615 | -30,185 | -27,635 | -24,119 |
| Other Operating Activity | 36,753 | 9,577 | 46,361 | 51,183 | 33,114 |
| Operating Cash Flow | $-45,975 | $-19,599 | $-125,097 | $-91,701 | $-75,294 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 46,323 | 25,505 | -29,146 | -44,302 | -33,455 |
| PPE Investments | -1,572 | -398 | -2,348 | -1,955 | -935 |
| Purchase Sale Intangibles | N/A | N/A | -887 | -887 | N/A |
| Other Investing Activity | 0 | 0 | -671 | -671 | 199 |
| Investing Cash Flow | $44,751 | $25,107 | $-32,165 | $-46,928 | $-34,191 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 7,375 | 7,375 | N/A |
| Common Stock Issued | N/A | N/A | 154,135 | 154,135 | 150,000 |
| Other Financing Activity | 137 | 0 | -3,444 | -3,594 | 3,856 |
| Financing Cash Flow | $137 | $N/A | $158,066 | $157,916 | $153,856 |
| Exchange Rate Effect | -1,355 | -645 | -27 | -98 | 423 |
| Beginning Cash Position | 60,178 | 60,178 | 59,401 | 59,401 | 59,401 |
| End Cash Position | 57,736 | 65,041 | 60,178 | 78,590 | 104,195 |
| Net Cash Flow | $-2,442 | $4,863 | $777 | $19,189 | $44,794 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,975 | -19,599 | -125,097 | -91,701 | -75,294 |
| Capital Expenditure | -1,572 | -398 | -2,348 | -1,955 | -935 |
| Free Cash Flow | -47,547 | -19,997 | -127,445 | -93,656 | -76,229 |